These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 15449184

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K, Kotzerke J.
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study.
    Yuan J, Liu C, Liu X, Wang Y, Kuai D, Zhang G, Zaknun JJ.
    Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120
    [Abstract] [Full Text] [Related]

  • 5. Rhenium-188-HEDP in the palliative treatment of bone metastases.
    Liepe K, Hliscs R, Kropp J, Grüning T, Runge R, Koch R, Knapp FF, Franke WG.
    Cancer Biother Radiopharm; 2000 Jun; 15(3):261-5. PubMed ID: 10941533
    [Abstract] [Full Text] [Related]

  • 6. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W, Kampen WU, Kampen AM, Henze E.
    J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
    [Abstract] [Full Text] [Related]

  • 7. Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP.
    Lam MG, Hoekstra A, de Klerk JM, van Rijk PP, Zonnenberg BA.
    Nuklearmedizin; 2009 Feb; 48(1):37-43. PubMed ID: 19212610
    [Abstract] [Full Text] [Related]

  • 8. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
    Dolezal J, Vizda J, Odrazka K.
    Urol Int; 2007 Feb; 78(1):50-7. PubMed ID: 17192733
    [Abstract] [Full Text] [Related]

  • 9. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
    Montesano T, Giacomobono S, Acqualagna G, Colandrea M, Di Nicola A, Travascio L, Giancamerla M, D'Apollo R, Toteda M, Ugolini F, Filesi M, Ronga G.
    Clin Ter; 2009 Feb; 160(3):193-9. PubMed ID: 19756320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.
    Ricci S, Boni G, Pastina I, Genovesi D, Cianci C, Chiacchio S, Orlandini C, Grosso M, Alsharif A, Chioni A, Di Donato S, Francesca F, Selli C, Rubello D, Mariani G.
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1023-30. PubMed ID: 17242920
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M, Czepczyński R, Milecki P, Pisarek M, Oleksa R, Sowiński J.
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [Abstract] [Full Text] [Related]

  • 15. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
    Róka R, Séra T, Pajor L, Thurzó L, Láng J, Csernay L, Pávics L.
    Orv Hetil; 2000 May 07; 141(19):1019-23. PubMed ID: 10846424
    [Abstract] [Full Text] [Related]

  • 16. A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.
    Resche I, Chatal JF, Pecking A, Ell P, Duchesne G, Rubens R, Fogelman I, Houston S, Fauser A, Fischer M, Wilkins D.
    Eur J Cancer; 1997 Sep 07; 33(10):1583-91. PubMed ID: 9389919
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
    Liepe K, Kropp J, Runge R, Kotzerke J.
    Br J Cancer; 2003 Aug 18; 89(4):625-9. PubMed ID: 12915868
    [Abstract] [Full Text] [Related]

  • 18. Samarium-153-EDTMP in bone metastases.
    Ahonen A, Joensuu H, Hiltunen J, Hannelin M, Heikkilä J, Jakobsson M, Jurvelin J, Kairemo K, Kumpulainen E, Kulmala J.
    J Nucl Biol Med (1991); 1994 Dec 18; 38(4 Suppl 1):123-7. PubMed ID: 7543288
    [Abstract] [Full Text] [Related]

  • 19. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H, Luo S, Tan T, Mo T, Liang Z, Pu M, Jiao J, Zhong S, Wang Q, Hu Y.
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec 18; 26(4):391-4. PubMed ID: 8732058
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.